1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Nadezhdin, K.D. Bocharova, O.V. Bocharov, E.V. Arseniev, A.S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking RU Acta Naturae 2075-8251 3 69 76 22649674 Structural and dynamic study of the transmembrane domain of the amyloid precursor protein. 2011 10.2210/pdb2llm/pdb pdb_00002llm 4450.460 Amyloid beta A4 protein UNP residues 686-726 1 man polymer ABPP, APPI, APP, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, CVAP, PreA4, Protease nexin-II, PN-II, N-APP, Soluble APP-alpha, S-APP-alpha, Soluble APP-beta, S-APP-beta, C99, Beta-amyloid protein 42, Beta-APP42, Beta-amyloid protein 40, Beta-APP40, C83, P3(42), P3(40), C80 no no GSQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKK GSQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKK A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample APP, A4, AD1 9606 Homo sapiens 562 Escherichia coli pGEMEX-1 database_2 pdbx_database_status pdbx_nmr_software pdbx_nmr_spectrometer struct_ref_seq_dif repository Initial release Data collection Database references Other 1 0 2012-06-20 1 1 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details BMRB Y RCSB 2011-11-15 REL REL REL REL structures with the least restraint violations 20 20 2D 1H-15N HSQC 2D 1H-13C HSQC 3D HNCO 3D HNCA 3D HN(CO)CA 3D HCCH-TOCSY 3D 1H-13C NOESY aliphatic 2D 1H-15N HSQC 3D 1H-15N NOESY 3D 1H-15N TOCSY 0.3-1 mM [U-100% 13C; U-100% 15N] 21-70 mM [U-100% 2H] 0.3-1 mM [U-100% 15N] 21-70 mM 20 4.6 ambient 318 K simulated annealing 1 fewest violations 0.3-1 mM [U-100% 13C; U-100% 15N] APPjmtm, 21-70 mM [U-100% 2H] DPC, 95% H2O/5% D2O 95% H2O/5% D2O 0.3-1 mM [U-100% 15N] APPjmtm, 21-70 mM DPC, 95% H2O/5% D2O 95% H2O/5% D2O Bruker Biospin collection TopSpin Bruker Biospin processing TopSpin Guntert, Mumenthaler and Wuthrich structure solution CYANA 2.1 Guntert, Mumenthaler and Wuthrich refinement CYANA 2.1 Koradi, Billeter and Wuthrich geometry optimization MOLMOL Koradi, Billeter and Wuthrich visualization MOLMOL Cornilescu, Delaglio and Bax refinement TALOS+ Cornilescu, Delaglio and Bax structure solution TALOS+ R.L.J.Keller chemical shift assignment CARA R.L.J.Keller data analysis CARA R.L.J.Keller peak picking CARA 600 Bruker AVANCE Bruker Avance 800 Bruker AVANCE Bruker Avance GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A GLN 3 n 3 GLN 3 A LYS 4 n 4 LYS 4 A LEU 5 n 5 LEU 5 A VAL 6 n 6 VAL 6 A PHE 7 n 7 PHE 7 A PHE 8 n 8 PHE 8 A ALA 9 n 9 ALA 9 A GLU 10 n 10 GLU 10 A ASP 11 n 11 ASP 11 A VAL 12 n 12 VAL 12 A GLY 13 n 13 GLY 13 A SER 14 n 14 SER 14 A ASN 15 n 15 ASN 15 A LYS 16 n 16 LYS 16 A GLY 17 n 17 GLY 17 A ALA 18 n 18 ALA 18 A ILE 19 n 19 ILE 19 A ILE 20 n 20 ILE 20 A GLY 21 n 21 GLY 21 A LEU 22 n 22 LEU 22 A MET 23 n 23 MET 23 A VAL 24 n 24 VAL 24 A GLY 25 n 25 GLY 25 A GLY 26 n 26 GLY 26 A VAL 27 n 27 VAL 27 A VAL 28 n 28 VAL 28 A ILE 29 n 29 ILE 29 A ALA 30 n 30 ALA 30 A THR 31 n 31 THR 31 A VAL 32 n 32 VAL 32 A ILE 33 n 33 ILE 33 A VAL 34 n 34 VAL 34 A ILE 35 n 35 ILE 35 A THR 36 n 36 THR 36 A LEU 37 n 37 LEU 37 A VAL 38 n 38 VAL 38 A MET 39 n 39 MET 39 A LEU 40 n 40 LEU 40 A LYS 41 n 41 LYS 41 A LYS 42 n 42 LYS 42 A LYS 43 n 43 LYS 43 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A SER 14 -159.28 74.61 1 A LYS 42 56.67 88.13 2 A VAL 12 -126.67 -72.38 2 A SER 14 -161.99 42.39 2 A ASN 15 -172.99 97.07 3 A SER 2 -130.96 -71.63 3 A LYS 4 -124.59 -50.27 3 A SER 14 -154.89 -68.38 3 A ASN 15 -122.52 -65.87 3 A LYS 16 -165.31 -74.42 3 A LYS 42 -172.47 130.83 5 A GLN 3 -113.32 55.37 5 A VAL 12 -134.74 -65.27 6 A GLN 3 -172.10 57.47 6 A LYS 4 -133.82 -49.05 6 A SER 14 -54.95 -74.12 6 A ASN 15 -162.04 27.94 7 A SER 2 58.70 79.50 7 A GLN 3 -145.10 32.89 7 A SER 14 -162.41 -74.28 7 A ASN 15 -150.89 -75.05 7 A LYS 16 -143.71 -74.21 8 A GLN 3 -96.91 49.04 8 A LYS 42 -58.53 -178.84 9 A SER 14 -175.37 82.86 9 A ASN 15 -152.02 -68.42 9 A LYS 16 -147.88 -74.30 10 A GLN 3 -150.50 42.16 10 A SER 14 -108.29 41.50 10 A ASN 15 59.26 77.41 10 A LYS 42 -170.50 -55.41 11 A LYS 41 60.73 96.90 12 A GLN 3 -174.93 52.34 12 A VAL 12 -151.93 76.34 12 A SER 14 -147.36 -67.39 12 A LYS 16 71.57 -69.54 13 A LYS 16 69.01 -75.73 13 A LYS 41 -65.85 -73.98 13 A LYS 42 59.01 177.77 14 A GLN 3 -142.74 33.73 14 A SER 14 -160.12 71.09 14 A ASN 15 -126.76 -68.33 14 A LYS 16 -143.91 -74.46 15 A GLN 3 -156.98 30.02 15 A VAL 12 -91.91 -68.60 15 A SER 14 56.51 86.41 15 A ASN 15 -169.70 85.57 15 A LYS 16 -87.39 -73.51 15 A LYS 41 61.79 96.78 15 A LYS 42 -94.50 -68.94 16 A SER 14 -179.38 97.56 16 A ASN 15 -116.28 -76.50 16 A LYS 16 -153.07 -75.44 16 A LYS 42 -68.12 89.33 17 A ASN 15 -175.02 98.69 18 A VAL 12 -92.40 -60.27 18 A ASN 15 -164.17 79.65 18 A LYS 42 -66.64 -169.78 19 A SER 14 -174.77 95.11 19 A ASN 15 -175.92 99.46 19 A LYS 42 -168.81 -65.70 20 A LYS 16 70.70 -70.21 20 A LYS 42 -143.46 -45.13 fewest violations, model 1 Structure of amyloid precursor protein's transmembrane domain 1 N N A LYS 4 A LYS 4 HELX_P A VAL 12 A VAL 12 1 1 9 A ASN 15 A ASN 15 HELX_P A LYS 42 A LYS 42 1 2 28 PROTEIN FIBRIL Alzheimer's disease, PROTEIN FIBRIL A4_HUMAN UNP 1 686 P05067 QKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKK 686 726 2LLM 3 43 P05067 A 1 3 43 1 expression tag GLY 1 2LLM A P05067 UNP 1 1 expression tag SER 2 2LLM A P05067 UNP 2